Insider Trading Arrangements

3 Months Ended

9 Months Ended

Sep. 30, 2024

shares

Sep. 30, 2024

shares

Trading Arrangements, by Individual

Non-Rule 10b5-1 Arrangement Adopted

false

Rule 10b5-1 Arrangement Terminated

false

Non-Rule 10b5-1 Arrangement Terminated

false

Richard Levy [Member]

Trading Arrangements, by Individual

Material Terms of Trading Arrangement

The following table shows the number of shares of our common stock subject to the current Rule 10b5-1 trading arrangements of our Section 16 officers and directors in place as of October 28, 2024:

Name of Director or Section 16 Officer	Title of Director or Section 16 Officer	Date of Adoption, Modification, or Termination	Duration of the Plan	Aggregate Number of Shares of Common Stock that may be Sold under the Plan
Richard Levy, MD	Director	11/30/2023	June 16, 2025	15,000

Name

Richard Levy, MD

Title

Director

Rule 10b5-1 Arrangement Adopted

true

Adoption Date

11/30/2023

Arrangement Duration

564 days

Aggregate Available

15,000

15,000